Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sjogren Disease”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Not applicableLooking for participantsNCT06875102
What this trial is testing

Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies

Who this might be right for
Sjogren Syndrome
Centre Hospitalier Universitaire de Saint Etienne 174
Large-scale testing (Phase 3)Active Not RecruitingNCT05946941
What this trial is testing

Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
Bristol-Myers Squibb 774
Testing effectiveness (Phase 2)Study completedNCT01647737
What this trial is testing

Green Tea Lozenges for the Management of Dry Mouth

Who this might be right for
XerostomiaSjogren SyndromeDry Mouth
Augusta University 60
Early research (Phase 1)WithdrawnNCT06411639
What this trial is testing

Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases

Who this might be right for
Sjogren DiseaseSystemic Lupus Erythematosus
Novartis Pharmaceuticals
Not applicableUnknownNCT05312944
What this trial is testing

Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome

Who this might be right for
Polymyalgia RheumaticaSjogren's Syndrome
University Hospital, Brest 15
Testing effectiveness (Phase 2)Looking for participantsNCT06828042
What this trial is testing

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSystemic Sclerosis (SSc)Sjogren Syndrome+3 more
Peking University Third Hospital 9
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension+1 more
Beijing GoBroad Hospital 45
Not applicableLooking for participantsNCT06732674
What this trial is testing

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

Who this might be right for
Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified ElsewhereSystemic Sclerosis PulmonaryDermatomyositis+3 more
Oslo University Hospital 218
Testing effectiveness (Phase 2)Ended earlyNCT04035668
What this trial is testing

Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome

Who this might be right for
Sjögren Syndrome
Novartis Pharmaceuticals 73
Not applicableUnknownNCT02132585
What this trial is testing

Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction

Who this might be right for
Sjogren Syndrome
University of Roma La Sapienza 700
Early research (Phase 1)Looking for participantsNCT07184450
What this trial is testing

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

Who this might be right for
Juvenile Dermatomyositis (JDM)Polyarticular Juvenile Idiopathic ArthritisSystemic Sclerosis (SSc)+1 more
Chongqing Precision Biotech Co., Ltd 11
Very early researchStudy completedNCT00460928
What this trial is testing

Preventive IVIG Therapy for Congenital Heart Block

Who this might be right for
Congenital Heart BlockNeonatal LupusAutoantibody-associated Heart Block
NYU Langone Health 20
Post-approval studies (Phase 4)Looking for participantsNCT07153276
What this trial is testing

TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE

Who this might be right for
Sjogren SyndromeSjogren DiseasePrimary Sjogren Syndrome
University of Sao Paulo General Hospital 60
Not applicableStudy completedNCT00565526
What this trial is testing

Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome

Who this might be right for
Sjogren's SyndromeDysautonomia
National Institute of Dental and Craniofacial Research (NIDCR) 28
Large-scale testing (Phase 3)Study completedNCT05425914
What this trial is testing

Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level

Who this might be right for
Dry Eye SyndromesHypovitaminosis D
University of Faisalabad 108
Large-scale testing (Phase 3)Study completedNCT05350072
What this trial is testing

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

Who this might be right for
Sjogren Syndrome
Novartis Pharmaceuticals 275
Large-scale testing (Phase 3)Study completedNCT06931041
What this trial is testing

Comparing Efficacy of Autologous Serum Eye Drops With and Without Insulin in Autoimmune Dry Eye.

Who this might be right for
Dry EyeSjogren Syndrome
Instituto de Oftalmología Fundación Conde de Valenciana 25
Early research (Phase 1)Looking for participantsNCT07041099
What this trial is testing

CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Who this might be right for
SjögrenSjogren DiseaseSjogren's Syndrome
Cullinan Therapeutics Inc. 36
Not applicableStudy completedNCT03327870
What this trial is testing

Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk Population

Who this might be right for
Sjogren's SyndromeOral Health
National Institute of Dental and Craniofacial Research (NIDCR) 166
Testing effectiveness (Phase 2)Ended earlyNCT04988087
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)

Who this might be right for
Sjogren SyndromeMixed Connective Tissue Disease
Novartis Pharmaceuticals 30
Next Page